September 11, 2018
Updated 2/16/2021
Updates were reviewed by Shazia K. Nakhoda, MD
While lymphoma is the most common type of blood cancer, there are many different subtypes that require nuanced treatment. Because of this, getting an accurate diagnosis and receiving... read more
August 10, 2018
Q. What is Chimeric Antigen Receptor (CAR) T-cell Therapy?
A. CAR T-cell therapy is just one kind of immunotherapy. In CAR T-cell therapy, immune cells known as T cells are extracted from a patient’s blood. They are then genetically altered to recognize... read more
May 16, 2018
Immunotherapy has been the most exciting development in bladder cancer treatment in recent years. Its introduction ended a 40-year drought during which no new therapies were available. Unfortunately, many bladder cancers can be resistant to immunotherapy.... read more
January 18, 2018
Few breakthroughs in battling cancer have generated more excitement recently than immunotherapy. It’s helping some patients—including high profile ones like former president Jimmy Carter—achieve long-term remission and possibly even a cure when their cancer... read more